Lucie Lafay‐Cousin

Integrated (epi)-Genomic Analyses Identify Subgroup-Specific Therapeutic Targets in CNS Rhabdoid Tumors

Jonathon Torchia, Brian Golbourn, Shengrui Feng et al. · Cancer Cell · 2016 · 251 citations · Full text

Tumor Biology, Radiation Oncology, Neuro-oncology +11

TP53 Alterations Determine Clinical Subgroups and Survival of Patients With Choroid Plexus Tumors

Uri Tabori, Adam Shlien, Berivan Baskin et al. · Journal of Clinical Oncology · 2010 · 236 citations

Immunohistochemical analysis of H3K27me3 demonstrates global reduction in group-A childhood posterior fossa ependymoma and is a powerful predictor of outcome

Pooja Panwalkar, Jonathan R. Clark, Vijay Ramaswamy et al. · Acta Neuropathologica · 2017 · 229 citations · Full text

Neuro-oncology, Global Reduction, Powerful Predictor +6

Phase II Weekly Vinblastine for Chemotherapy-Naïve Children With Progressive Low-Grade Glioma: A Canadian Pediatric Brain Tumor Consortium Study

Álvaro Lassaletta, Katrin Scheinemann, Shayna Zelcer et al. · Journal of Clinical Oncology · 2016 · 228 citations · Full text

Central nervous system atypical teratoid rhabdoid tumours: The Canadian Paediatric Brain Tumour Consortium experience

Lucie Lafay‐Cousin, Cynthia Hawkins, Anne‐Sophie Carret et al. · European Journal of Cancer · 2011 · 211 citations

Neuro-oncology, Tumoral Pathology, Pediatric Brain Tumors +6